Hemodynamic Markers Predict Outcomes a Decade After Acute Coronary Syndrome

Andrzej Minczykowski1, Oskar Wojciech Wiśniewski1,2, Tomasz Krauze1

  • 1Department of Cardiology-Intensive Therapy, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

Journal of Clinical Medicine
|September 27, 2025
PubMed

Insights

Novel hemodynamic markers, including ventricular-arterial coupling and excess aortic pressure, significantly predict long-term mortality risk in acute coronary syndrome survivors over 10 years.

Area of Science:

  • Cardiology
  • Clinical Research
  • Hemodynamics

Background:

  • Previous research identified novel hemodynamic indices for predicting 3-5-year mortality in myocardial infarction survivors.
  • This study extends the investigation to assess the long-term (10-year) prognostic value of these markers.

Purpose of the Study:

  • To evaluate the long-term prognostic significance of novel hemodynamic indices in predicting 10-year all-cause mortality.
  • To determine if markers like ventricular-arterial coupling, excess aortic pressure, and pulse wave velocity/global longitudinal peak systolic strain index offer independent predictive value.

Main Methods:

  • Prospective study of 569 acute coronary syndrome patients with >50% coronary artery stenosis.
  • Assessment of ejection fraction (EF), global longitudinal peak systolic strain (GLPSS), ventricular-arterial (VA) coupling, excess aortic pressure (excess PTI), and pulse wave velocity (PWV).
  • 10-year follow-up for all-cause mortality.

Main Results:

  • 172 deaths occurred during a median follow-up of 3249 days.
  • Lower EF, impaired VA coupling, higher excess PTI, and lower PWV/GLPSS index were associated with mortality.
  • Multivariate analysis confirmed EF, VA coupling, excess PTI, and PWV/GLPSS index as independent predictors of 10-year mortality.

Conclusions:

  • Novel hemodynamic indices, including VA coupling, PWV/GLPSS index, and excess PTI, possess significant long-term prognostic value.
  • These markers effectively predict 10-year all-cause mortality in patients with acute coronary syndrome.
  • The findings support the clinical utility of these hemodynamic markers for risk stratification in ACS survivors.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
800
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
540
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
361
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
812
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
730